Image
27.11.2025
Our response to the November 2025 Budget
On Wednesday 26th November, the Chancellor delivered the November 2025 Budget, which included new measure...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more